Backed by NIH, DNA Nanobots aims to disrupt gene therapy with scalable, non-viral platform—$5M round now open to select investors. We're at a pivotal moment, with platform validation and NIH support, ...

Recent studies show that senescent cells accumulate several species of cytosolic DNAs, including mitochondrial DNA (mtDNA), cytoplasmic chromatin fragments (CCFs), and retrotransposable element cDNAs, ...